These results suggest that FMOD promotes breast cancer cell metastasis through (being a downstream effector of) the Wnt/β-catenin pathway which is sensitive to Aspirin inhibition, and wherein the gene products play vital, specific and interrelated roles. The gene discussed is FMOD; the disease is breast carcinoma.